We also evaluated the MINK1 expression in drug-naive and post-CT non-responder paired tumor samples from the same patient and observed that the post–CT-treated tumor samples showed higher MINK1 expression (Fig. 1J, K and Table S3). The gene discussed is MINK1; the disease is neoplasm.